Baloxavir Intermediates 01
1985605-59-1
Pharmaceutical Grade
99%
Shanghai
Alicorn
25kg/Cardboard Drum
2023-09-21
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceBaloxavir is under investigation in clinical trial NCT04327791 (Combination Therapy With Baloxavir and Oseltamavir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)).|Baloxavir is a Polymerase Acidic Endonuclease Inhibitor. The mechanism of action of baloxavir is as a Polymerase Acidic Endonuclease Inhibitor, and Chelating Activity.|Baloxavir is an inhibitor of the influenza cap-dependent endonuclease enzyme and is used as therapy of influenza A and B. Baloxavir is given as a single, one-time dose and has not been associated with serum enzyme elevations or with clinically apparent liver injury.Basic Info
-
Product Name:
Baloxavir
Other Name:Baloxavir;CPD2051;Baloxavir Impurity 10;New Baloxavir;1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-, (12aR)-;Baloxavir USP/EP/BP;Baloxavir (Xofluza;1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione,12-[(11S)-7Chemicalbook,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-,(12aR)-
CAS No.:1985605-59-1
Molecular Formula:C24H19F2N3O4S
InChIKeys:FIDLLEYNNRGVFR-CTNGQTDRSA-N
Molecular Weight:483.49
Exact Mass:483.10643359
EC Number:200-001-8
UNII:4G86Y4JT3F
Color/Form:White to yellow
Categories:
Characteristics-
Density:
1.63±0.1 g/cm3(Predicted)
Boiling Point:644.7±65.0 °C(Predicted)
PKA:4.50±1.00(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Location:
Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
20
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
201-300
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product